Announced Mon, 28 Sept, 2026 · 17:50 IST
Valiant Labs 5th AGM: Debt-free, subsidiary ops begin, 18 resolutions passed
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.8%1-day move
₹118.95
prior close
₹121.85
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-4.0-5.6-4.0+6.8+3.9+6.3+6.1+4.1—————
Up moveDown movePending
AI summary
Valiant Labs held its 5th AGM on Sep 28, 2026 via video conferencing with 38 members. MD reported improved FY26 performance, stabilising paracetamol API market, successful Rights Issue, and debt-free balance sheet. Subsidiary Valiant Advanced Sciences began commercial operations in specialty chemicals. FY27 focus on subsidiary growth, exports, and certifications. 18 resolutions passed including related party deals with group firms, MD re-appointment, and registered office shift.
Likely market impact
Positive signals: debt-free status, Rights Issue done, subsidiary ops launched. E-voting results awaited for final confirmation.